Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes

被引:309
作者
Dayan, N
Touitou, E [1 ]
机构
[1] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Dept Pharmaceut, Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Fac Med, David R Bloom Ctr Pharm, Jerusalem, Israel
关键词
trihexyphenidyl; ethosomes; liposomes; skin; permeation enhancement; transdermal delivery; Parkinson; surface activity;
D O I
10.1016/S0142-9612(00)00063-6
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The purpose of this work was to characterize a novel ethosomal carrier containing trihexyphenidyl HCl (THP) and to investigate the delivery of THP from ethosomes versus classic liposomes. THP-ethosomal systems were shown by electron microscopy to contain small, phospholipid vesicles. As the THP concentration was increased from 0 to 3%, the size of the vesicles decreased from 154 to 90 nm. This is most likely due to the surface activity of THP (critical micelle concentration of 5.9 mg/ml), as measured in this work. In addition, the ethosome zeta potential value increased as a function of THP concentration, from -4.5 to +10.4 when the THP concentration was increased from 0 to 3%. In contrast, THP liposomes were much larger and their charge was not affected by THP. When compared with standard liposomes, ethosomes had a higher entrapment capacity and a greater ability to deliver entrapped fluorescent probe to the deeper layers of skin. The flux of THP through nude mouse skin from THP ethosomes (0.21 mg/cm(2) h) was 87, 51 and 4.5 times higher than from liposomes, phosphate buffer and hydroethanolic solution, respectively (p < 0.01). The quantity of THP remaining in the skin at the end of the 18-h experiment was statistically significantly greater from the ethosomal system than from liposomes or a control hydroethanolic solution. Our results indicate that the ethosomal THP system may be a promising candidate for transdermal delivery of THP. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1879 / 1885
页数:7
相关论文
共 15 条
  • [1] AGGREGATION OF ANTI-ACETYLCHOLINE DRUGS IN AQUEOUS-SOLUTION - MICELLAR PROPERTIES OF SOME DIPHENYLMETHANE DERIVATIVES
    ATTWOOD, D
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (05) : 407 - 409
  • [2] PHARMACOKINETICS OF TRIHEXYPHENIDYL AFTER SHORT-TERM AND LONG-TERM ADMINISTRATION TO DYSTONIC PATIENTS
    BURKE, RE
    FAHN, S
    [J]. ANNALS OF NEUROLOGY, 1985, 18 (01) : 35 - 40
  • [3] Elka Touitou, 1996, US patent, Patent No. [5540934A, 5540934, US5540934A]
  • [4] GILMAN AG, 1992, PHARMACOL BASIS THER, P160
  • [5] The preparation of tissue-type plasminogen activator (t-PA) containing liposomes: Entrapment efficiency and ultracentrifugation damage
    Heeremans, JLM
    Gerritsen, HR
    Meusen, SP
    Mijnheer, RW
    Panday, RSG
    Prevost, R
    Kluft, C
    Crommelin, DJA
    [J]. JOURNAL OF DRUG TARGETING, 1995, 3 (04) : 301 - 310
  • [6] HERNANDEZBORRELL J, 1990, J MICROENCAPSUL, V7, P255
  • [7] Testosterone skin permeation enhancement by menthol through formation of eutectic with drug and interaction with skin lipids
    KaplunFrischoff, Y
    Touitou, E
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (12) : 1394 - 1399
  • [8] MCINNIS M, 1985, ACTA PSYCHIAT SCAND, V71, P297
  • [9] NEW RRC, 1990, LIPOSOMES PRACTICAL, P36
  • [10] PRADAS TNV, 1992, PHARMAZIE, V47, P231